Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gratwohl

Showing results (351-360 of 381) with videos related to

Pageof 39
Sort By:
Bone Marrow Transplantation|December 2, 2008
Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity reportM D Aljurf, S Z Zaidi, H El Solh, et al.
Annals of Hematology|September 14, 2000
Transplant activities in Germany in 1998--a survey facilitated by the National Registry for Hemopoietic Stem Cell TransplantationH D Ottinger, C Müller, N Schmitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2012
Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categoriesJan J Cornelissen, Dimitri Breems, Wim L J van Putten, et al.
Bone Marrow Transplantation|July 23, 1998
Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemiaJ R Passweg, P A Rowlings, K A Atkinson, et al.
Bone Marrow Transplantation|February 23, 2016
Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global surveyD Niederwieser, H Baldomero, J Szer, et al.
Bone Marrow Transplantation|October 23, 1997
Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationF van Rhee, R M Szydlo, J Hermans, et al.
Bone Marrow Transplantation|July 22, 1999
Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia?E Vellenga, W L van Putten, M A Boogaerts, et al.
Blood|November 26, 1999
Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedureR Hehlmann, A Hochhaus, H J Kolb, et al.
Bone Marrow Transplantation|July 10, 2012
Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT)J P Halter, S M van Walraven, N Worel, et al.
Bone Marrow Transplantation|July 1, 1997
European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationA Devergie, J F Apperley, M Labopin, et al.
Pageof 39

Showing results (351-360 of 381) with videos related to

Sort By:
Pageof 39
Bone Marrow Transplantation|December 2, 2008
Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity reportM D Aljurf, S Z Zaidi, H El Solh, et al.
Annals of Hematology|September 14, 2000
Transplant activities in Germany in 1998--a survey facilitated by the National Registry for Hemopoietic Stem Cell TransplantationH D Ottinger, C Müller, N Schmitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2012
Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categoriesJan J Cornelissen, Dimitri Breems, Wim L J van Putten, et al.
Bone Marrow Transplantation|July 23, 1998
Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemiaJ R Passweg, P A Rowlings, K A Atkinson, et al.
Bone Marrow Transplantation|February 23, 2016
Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global surveyD Niederwieser, H Baldomero, J Szer, et al.
Bone Marrow Transplantation|October 23, 1997
Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationF van Rhee, R M Szydlo, J Hermans, et al.
Bone Marrow Transplantation|July 22, 1999
Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia?E Vellenga, W L van Putten, M A Boogaerts, et al.
Blood|November 26, 1999
Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedureR Hehlmann, A Hochhaus, H J Kolb, et al.
Bone Marrow Transplantation|July 10, 2012
Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT)J P Halter, S M van Walraven, N Worel, et al.
Bone Marrow Transplantation|July 1, 1997
European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationA Devergie, J F Apperley, M Labopin, et al.
Pageof 39